Evidence map›Paper›PMID 40196824›Full record

ArticleRSC advances2025

Predicting p

Tatum K Harvey, Kristof Pota, Magy M Mekhail, David M Freire, Donatus A Agbaglo, Benjamin G Janesko, Kayla N Green

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Design of bifunctional pyridinophane ligands as MnInorganic chemistry frontiers · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tatum K HarveyDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0009-0002-9417-0694
Kristof PotaDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0000-0002-9027-0201
Magy M MekhailDepartment of Chemistry, University of California Irvine USA mamekhai@uci.edu.
David M FreireDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0000-0002-0976-2680
Donatus A AgbagloDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0000-0002-1344-9734
Benjamin G JaneskoDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0000-0002-2572-5273
Kayla N GreenDepartment of Chemistry & Biochemistry, Texas Christian University 2800 S. University Dr. Fort Worth TX 76129 USA kayla.green@tcu.edu b.janesko@tcu.edu.ORCID https://orcid.org/0000-0001-8816-7646

Funding

Targeting oxidative stress in neurodegeneration using pyridol-derived small moleculesR15GM123463 · NIGMS · TEXAS CHRISTIAN UNIVERSITY · PI AKKARAJU, GIRIDHAR, CHUMLEY, MICHAEL J · 2018 to 2025
$1.2M
NIGMS NIH HHS R15 GM123463
6 · The paper itself

Abstract

We present physics-based p

Identifiers

PMID40196824
PMCPMC11973477

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.